No Data
No Data
EU Pharma Majors Sanofi, Roche Trade Flat After Reiterated Guidance
AstraZeneca Enters $200m AI Cancer Pact With Tempus and Pathos
Earnings Preview: AstraZeneca to Report Financial Results Pre-market on April 29
BTIG Says AstraZeneca Deal Demonstrates Value of Tempus AI Data AI Business
Tempus AI Shares Rise After Deals With AstraZeneca, Pathos AI
AstraZeneca CEO Urges Europe to Spend More on Health or Risk Falling Behind -- Market Talk